Limited time75% off all plans
Get the app

Magnesium handling

Magnesium handling

Magnesium handling

On this page

Mg²⁺ Reabsorption Sites - The Magnesium Journey

Renal Magnesium Handling in PCT, TALH, and DCT

Magnesium reabsorption is primarily a passive, paracellular process driven by electrochemical gradients established by other transporters. The Thick Ascending Limb is the key site.

  • Thick Ascending Limb (TAL): The major site of Mg²⁺ reabsorption (60-70%).
    • Mechanism: Passive, paracellular movement driven by the lumen-positive potential created by the Na-K-2Cl (NKCC2) cotransporter.
    • 📌 Thick Ascending Limb Loves Mg²⁺ (TALL-Mg).
  • Distal Convoluted Tubule (DCT): Reabsorbs 5-10% via active transcellular transport through TRPM6 channels.

⭐ Loop diuretics inhibit the NKCC2 cotransporter in the TAL, which ↓ the lumen-positive potential. This impairs paracellular reabsorption of both Mg²⁺ and Ca²⁺, leading to hypomagnesemia and hypocalcemia.

Regulation of Reabsorption - Magnesium's Master Controls

  • Primary Regulatory Site: Thick Ascending Limb (TAL) of Henle's loop, reabsorbing 60-70% of filtered $Mg^{2+}$ via a paracellular route.

    • This transport depends on a lumen-positive potential generated by the Na-K-2Cl cotransporter (NKCC2) and ROMK channel.
    • Proteins claudin-16 and claudin-19 form the paracellular channels.
  • Factors ↑ Reabsorption:

    • Parathyroid Hormone (PTH): Upregulates TAL $Mg^{2+}$ transport.
    • Hypomagnesemia & Hypocalcemia: Decrease activation of the CaSR, promoting reabsorption.
  • Factors ↓ Reabsorption (leading to Mg²⁺ wasting):

    • Hypermagnesemia & Hypercalcemia: Activate the basolateral Calcium-Sensing Receptor (CaSR), inhibiting reabsorption.
    • Loop Diuretics (e.g., Furosemide): Inhibit NKCC2, reducing the driving force for paracellular transport.
    • Volume Expansion.
    • Metabolic Acidosis.

Exam Favorite: Activating mutations in the Calcium-Sensing Receptor (CaSR) cause familial hypocalcemia with hypercalciuria, but also lead to significant hypomagnesemia due to suppressed TAL reabsorption.

Clinical Correlations - Too Much, Too Little

  • Hypermagnesemia (>2.2 mEq/L)

    • Causes: Chronic kidney disease, iatrogenic (e.g., MgSO₄ for eclampsia, antacids/laxatives).
    • Symptoms: ↓ Deep tendon reflexes (DTRs), lethargy, respiratory depression, bradycardia, cardiac arrest.
    • Treatment: IV Calcium Gluconate (antagonizes Mg²⁺ effects), saline diuresis, possible hemodialysis.
  • Hypomagnesemia (<1.8 mEq/L)

    • Causes: Diuretics (loop & thiazide), PPIs, alcoholism, diarrhea, amphotericin B.
    • Symptoms: Neuromuscular hyperexcitability (tetany, fasciculations, seizures), arrhythmias (Torsades de Pointes).

    ⭐ Hypomagnesemia frequently causes refractory hypokalemia and hypocalcemia. It impairs PTH release and function, and promotes renal K⁺ wasting.

ECG: Torsades de Pointes and MgSO4 treatment

High‑Yield Points - ⚡ Biggest Takeaways

  • ~60-70% of filtered Mg²⁺ is reabsorbed in the thick ascending limb (TAL), mainly via the paracellular route.
  • Transport is driven by the lumen-positive potential generated by the Na-K-2Cl (NKCC2) cotransporter.
  • Loop diuretics (e.g., Furosemide) are a major cause of hypomagnesemia by inhibiting the NKCC2.
  • The Calcium-Sensing Receptor (CaSR) activation by high Ca²⁺ or Mg²⁺ inhibits reabsorption in the TAL.
  • Hypomagnesemia can cause refractory hypokalemia and hypocalcemia.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE